Further validation and threshold determination of Brazilian-Portuguese version of the Chronic Urticaria Quality of Life Questionnaire (CU-Q2oL)
British Journal of Dermatology · 18.08.2026 · 195 (3) · 530-532
DOI: 10.1093/bjd/ljag242 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Dermatology, online erschienen am 16.06.2026. Verfasst von João Marcelino und 11 weiteren Autor:innen. Beteiligte Einrichtung: Immunology and Clinical Allergology Department, Hospital de São Bernardo, Unidade Local de Saúde da Arrábida (ULSA), Setúbal, Portugal. Die Arbeit nennt 8 Literaturangaben.
Abstract (Originalsprache)
Chronic spontaneous urticaria (CSU) markedly affects quality of life (QoL), and this study evaluated the Brazilian-Portuguese Chronic Urticaria Quality of Life Questionnaire (CU-Q2oL) in 169 patients with CSU, examining its validity, correlations with established patient-reported outcomes, and clinically meaningful severity cutoffs. CU-Q2oL scores correlated strongly with the Dermatology Life Quality Index (DLQI), moderately with the Weekly Urticaria Activity Score (UAS7), and inversely with the Urticaria Control Test (UCT), and a data-driven four-tier severity model showed excellent discriminatory performance. These findings support the CU-Q2oL as a valid QoL instrument in CSU and suggest that the four-tier scoring system may improve clinical stratification and treatment planning.
Autor:innen und Institutionen
- Immunology and Clinical Allergology Department, Hospital de São Bernardo, Unidade Local de Saúde da Arrábida (ULSA), Setúbal, Portugal.
- Institute of Allergology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
- Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Immunology and Allergology, Berlin, Germany.
- Immunology and Clinical Allergology Department, Hospitais da Universidade de Coimbra, Unidade Local de Saúde de Coimbra, Coimbra, Portugal.
- Faculty of Medicine, University of Coimbra, Coimbra, Portugal.
- Center for Innovative Biomedicine and Biotechnology (CIBB), Faculty of Medicine, University of Coimbra, Portugal.
ORCID-Profile: João Marcelino, Felix Aulenbacher, Helena Pereira, Frederico Regateiro, Ana Todo-Bom, Leonor Leão, Diogo Mota, Ruben Ferreira, Alice Horta, Joana Guimarães, Elza Tomaz, Martin Metz
Zitieren
APA
Marcelino, J., Aulenbacher, F., Pereira, H., Regateiro, F., Todo-Bom, A., Leão, L., Mota, D., Ferreira, R., Horta, A., Guimarães, J., Tomaz, E., & Metz, M. (2026). Further validation and threshold determination of Brazilian-Portuguese version of the Chronic Urticaria Quality of Life Questionnaire (CU-Q2oL). British Journal of Dermatology, 195(3), 530-532. https://doi.org/10.1093/bjd/ljag242
Vancouver
Marcelino J, Aulenbacher F, Pereira H, Regateiro F, Todo-Bom A, Leão L, et al. Further validation and threshold determination of Brazilian-Portuguese version of the Chronic Urticaria Quality of Life Questionnaire (CU-Q2oL). British Journal of Dermatology. 2026;195(3):530-532. doi:10.1093/bjd/ljag242
BibTeX
@article{Marcelino2026,
author = {Marcelino, João and Aulenbacher, Felix and Pereira, Helena and Regateiro, Frederico and Todo-Bom, Ana and Leão, Leonor and Mota, Diogo and Ferreira, Ruben and Horta, Alice and Guimarães, Joana and Tomaz, Elza and Metz, Martin},
title = {Further validation and threshold determination of Brazilian-Portuguese version of the Chronic Urticaria Quality of Life Questionnaire (CU-Q2oL)},
journal = {British Journal of Dermatology},
year = {2026},
volume = {195},
number = {3},
pages = {530--532},
doi = {10.1093/bjd/ljag242}
}
EUVIMED